Floatz logo

Alphanate Sd/Ht

Von Willebrand Disease

Grifols Biologicals, LLCPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Von Willebrand Disease cohort.

Asset / SponsorPhaseRating
FACTOR VIII (HUMAN)
Bio Products Laboratory
Phase 3BB
INTERLEUKIN-11
University of Pittsburgh
Phase 2B
Oprelvekin
University of Pittsburgh
Phase 2CCC
Von Willebrand Factor
National Center for Research Resources (NCRR)
Phase 1CC
HUMAN ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX
Assiut University
D
Tranexamic Acid
Assiut University
D
Cyclokapron
Mary M. Gooley Hemophilia Center
N/ANR
Rondaptivon pegol sodium
Medical University of Vienna
Phase 2NR

Same molecule, other indications

Alphanate Sd/Ht is also rated in:

severe hemophilia ADormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →